SCHEMBL581024

SCHEMBL581024

N#CC1C=NCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2041622 0.64
SCHEMBL9045723 0.60
SCHEMBL2040738 0.60
SCHEMBL25959129 0.59
SCHEMBL2042577 0.59
SCHEMBL5730522 0.58
SCHEMBL4061595 0.54
SCHEMBL385496 0.53
SCHEMBL1993310 0.52
SCHEMBL1997882 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069390-A2 OPSIN STABILIZING COMPOUNDS AND METHODS OF USE University of Florida Research Foundation, Inc. (US) 2009-06-17 EP claimed
WO-2008013983-A2 OPSIN STABILIZING COMPOUNDS AND METHODS OF USE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2008-01-31 WO claimed
EP-3373936-A1 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS Bayer Pharma Aktiengesellschaft (DE) 2018-09-19 EP disclosed
WO-2017081044-A1 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-05-18 WO disclosed
EP-2417112-A1 SULFONIC AMIDE AND SULFOXIMINE-SUBSTITUTED DIARYL-DIHYDROPYRIMIDINONES AND USAGE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2012-02-15 EP disclosed
WO-2010115548-A1 SULFONIC AMIDE AND SULFOXIMINE-SUBSTITUTED DIARYL-DIHYDROPYRIMIDINONES AND USAGE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-10-14 WO disclosed